共 10 条
- [1] ELISA vs. HMSA: a comparison between two different methods for the evaluation of adalimumab serum concentration and anti-adalimumab antibodies - Preliminary data [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S278 - S278
- [3] Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S166 - S166
- [6] Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2023, 8 (06): : 1054 - 1064
- [8] Homogenous Mobility Shift Assay (HMSA) Overcomes the Limitations of ELISA and ECLIA Assays for Monitoring Infliximab (IFX), Adalimumab (ADA), and Associated Anti-drug Antibodies in Serum [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S548 - S548
- [9] IMPACT OF ADALIMUMAB SERUM CONCENTRATION ON EFFICACY AND ASSOCIATION BETWEEN ANTI-DRUG ANTIBODIES AND SERUM CONCENTRATION: 24 WEEK RESULTS FROM A PHASE III STUDY COMPARING SB5 (AN ADALIMUMAB BIOSIMILAR) WITH REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 136 - 136